REPRESENTING THE THIRD DISTRICT OF MISSISSIPPI
COMMITTED TO CREATING JOBS, DRIVING DOWN SPENDING AND SHRINKING THE SIZE OF THE FEDERAL GOVERNMENT.

Rep. Harper Responds to the Passage of the 21st Century Cures Act

WASHINGTON, D.C. – Upon House passage of the 21st Century Cures Act—legislation introduced by the Energy and Commerce Committee to revolutionize medical innovation and research and bring it into the 21st Century—Congressman Gregg Harper (R-Miss.) issued the following statement:

“I am so pleased that the 21st Century Cures Act passed the House this evening. This bill is going to fundamentally transform the way we find cures by revolutionizing scientific collaboration and promoting medical innovation,” said Congressman Harper. “I am honored to be a co-sponsor of this bill to reduce the burdens and regulations holding us back and bring our health care infrastructure into the 21st century to deliver hope for patients and their loved ones.”

The 21st Century Cures Act passed today 392-26. The bill works to bring the national health care infrastructure into the modern age of technology and digital innovation by accelerating the cycle of discovery, development and delivery of new cures and treatments that will ensure the United States remains the global leader in biomedical innovation.

Institutions like the University of Mississippi Medical Center will benefit from the bill’s focus on precision medicine, innovation at the FDA, investments in the next generation of medical researchers, support for advancing translational science, and support for the national pediatric research network. The state of Mississippi and UMMC are already at the forefront of medical innovation and the 21st Century Cures Act will only serve to encourage further medical breakthroughs.

The highlights of the Cures legislation accelerates cutting-edge research and personalized drug development, modernizes clinical trials and evidence development. The legislation aims to bring the FDA into the 21st century by utilizing flexible approaches to reviewing medical devices that represent breakthrough technologies, and creating regulatory modernization—giving them the funding to recruit and retain the best and brightest scientists, doctors and engineers.

 

###